Family History and Triple-Negative Breast Cancer: What to Know
Photo Credit: kate_sept2004 / Getty Images
SOURCES:
Kimberley Lee, MD, assistant member, department of breast oncology, Moffitt Cancer Center.
Rachel Greenup, MD, associate professor of surgery (oncology, breast), Yale School of medicine; chief, breast surgery, The Breast Center at Smilow Cancer Hospital.
Anne Marie McCarthy, PhD, assistant professor of epidemiology, Perelman School of Medicine, University of Pennsylvania.
Eric Winer, MD, professor of pharmacology; professor of medicine (medical oncology), Yale School of Medicine; director, Yale Cancer Center; physician-in-chief, Smilow Cancer Network.
Frontiers in Molecular Biosciences: “Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence.”
American Cancer Society: “Breast Cancer Risk Factors You Cannot Change,” “Study: New Genes Linked With Triple-Negative Breast Cancer,” “American Cancer Society Recommendations for the Early Detection of Breast Cancer.”
Journal of the National Cancer Institute: “Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing.”
CDC: “Family Health History and the BRCA1 and BRCA2 genes,” “Family Health History Risk Categories,” “BRCA Gene Mutations.”
Current Breast Cancer Reports: “Disparities in Genetic Testing and Care among Black women with Hereditary Breast Cancer.”
JAMA Surgery: “Evaluation of Triple-Negative Breast Cancer Early Detection via Mammography Screening and Outcomes in African American and White American Patients.
